Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

B cell-derived IL35 drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

ABSTRACT: B cell-derived IL35 drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

PROVIDER: PRJNA603804 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10987245_1.fastq.gz	Fastqsanger.gz
	SRR10987245_2.fastq.gz	Fastqsanger.gz
	SRR10987246_1.fastq.gz	Fastqsanger.gz
	SRR10987246_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

B cell-Derived IL35 Drives STAT3-Dependent CD8<sup>+</sup> T-cell Exclusion in Pancreatic Cancer.

Project description:Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignancy characterized by a paucity of tumor-proximal CD8+ T cells and resistance to immunotherapeutic interventions. Cancer-associated mechanisms that elicit CD8+ T-cell exclusion and resistance to immunotherapy are not well-known. Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells. Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFNγ expression. Inhibition of STAT3 signaling in tumor-educated CD8+ T cells improved PDA growth control upon adoptive transfer to tumor-bearing mice. We showed that activation of STAT3 in CD8+ T cells was driven by B cell- but not regulatory T cell-specific production of IL35. We also demonstrated that B cell-specific deletion of IL35 facilitated CD8+ T-cell activation independently of effector or regulatory CD4+ T cells and was sufficient to phenocopy therapeutic anti-IL35 blockade in overcoming resistance to anti-PD-1 immunotherapy. Finally, we identified a circulating IL35+ B-cell subset in patients with PDA and demonstrated that the presence of IL35+ cells predicted increased occurrence of phosphorylated (p)Stat3+CXCR3-CD8+ T cells in tumors and inversely correlated with a cytotoxic T-cell signature in patients. Together, these data identified B cell-mediated IL35/gp130/STAT3 signaling as an important direct link to CD8+ T-cell exclusion and immunotherapy resistance in PDA.

| S-EPMC7056532 | biostudies-literature

STAT3 regulates CD8+ T cell differentiation and functions in cancer [ATAC-seq]

Project description:In cancer, persistent antigens drive CD8+ T cell differentiation into exhausted progenitor (Texprog) and terminally exhausted (Texterm) cells. However, how the extrinsic and intrinsic regulatory mechanisms cooperate during this process still remain not well understood. Here, we found STAT3 signaling plays essential roles in promoting intra-tumor Texterm cell development, by enhancing their effector functions and survival, which results in better tumor control. In tumor microenvironments, STAT3 is predominantly activated by IL-10 and IL-21, but not IL-6. Besides, STAT3 also plays critical roles in the development and function of terminally differentiated effector CD8+ T cells in acute infection. Mechanistically, STAT3 transcriptionally promotes the expression of effector function-related genes, while suppresses those expressed by progenitor Tex subset. Moreover, STAT3 functions in collaboration with BATF and IRF4 to mediate chromatin activation at effector gene loci. Thus, we have elucidated the roles of STAT3 signaling in terminally differentiated CD8+ T cell development, especially in cancer, which benefits developing more effective immunotherapies against tumor.

2022-12-25 | GSE217372 | GEO

STAT3 regulates CD8+ T cell differentiation and functions in cancer [RNA-seq]

2022-12-25 | GSE217375 | GEO

STAT3 regulates CD8+ T cell differentiation and functions in cancer [ChIP-seq]

2022-12-25 | GSE217374 | GEO

Constitutive CD8 expression drives innate CD8+ T cell differentiation via induction of iNKT2 subset

Project description:Constitutive CD8 expression drives innate CD8+ T cell differentiation via induction of iNKT2 subset.

2019-06-01 | GSE132059 | GEO

Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg cell-dependent CD8+ T cell exclusion

Project description:Tumor-intrinsic signaling pathways can drastically affect the tumor immune microenvironment (TME), promoting tumor progression and resistance to immunotherapy by excluding immune cell populations from the tumor. Several tumor-cell intrinsic pathways have been reported to modulate myeloid cell infiltration and subsequent T cell recruitment. Clinical evidence suggests that excluding cytotoxic T cells from the tumor core mediates resistance to immunotherapy. Here, we find that tumor cell-intrinsic SOX2 expression in non-small cell lung cancer induces the exclusion of cytotoxic T cells from the tumor core and promotes resistance to checkpoint blockade therapy. CD8+ T cell exclusion was dependent on regulatory T cell-mediated suppression of tumor vasculature. Depleting tumor-infiltrating regulatory T cells via Glucocorticoid-Induced TNFR-Related protein (GITR) restored CD8+ T cell infiltration and, combined with checkpoint blockade therapy, reduced tumor growth.

2024-12-19 | GSE256071 | GEO

STAT3 regulates CD8+ T cell differentiation and functions in cancer

Project description:STAT3 regulates CD8+ T cell differentiation and functions in cancer

| PRJNA898640 | ENA

Effect of STAT3-/+ secretome in CD8+ T cells in vitro culture

Project description:To investigate the effect of the addition of STAT3-/+ astrocyte derived-conditioned medium in CD8+ T cells previously activated in vitro We then performed gene expression profiling analysis using data obtained from RNA-seq of 3 CD8+ T cells cultures of STAT3- conditon and 3 CD8+ T cells cultures of STAT3+ conditon

2024-08-30 | GSE228364 | GEO

STAT3 regulates CD8+ T cell differentiation and functions in cancer [ATAC-seq]

Project description:STAT3 regulates CD8+ T cell differentiation and functions in cancer [ATAC-seq]

| PRJNA898636 | ENA

STAT3 regulates CD8+ T cell differentiation and functions in cancer [ChIP-seq]

Project description:STAT3 regulates CD8+ T cell differentiation and functions in cancer [ChIP-seq]

| PRJNA898637 | ENA